|
Celprogen Introduces an in vivo Model for Human Brain Cancer for Drug Discovery Applications
19 November 2008
Celprogen’s in vivo model system would enable scientists all over the world to test their potential drug candidates against Human Brain Cancer.
|
|
|
|
Cryo-Cell Announces Partnership with National Institutes of Health
19 November 2008
The collaboration will evaluate menstrual stem cells for future potential breast cancer therapy.
|
|
|
|
Identigene Expands Sales of Over-the-Counter DNA Paternity Test Kit to Discount Stores and Supercenters
19 November 2008
The Identigene DNA paternity test kit is said to be the first DNA paternity test ever sold in major retail outlets.
|
|
|
|
Purdue Researcher Invents Molecule that Stops SARS
18 November 2008
A Purdue University researcher has created a compound that prevents replication of the virus that causes SARS and could lead to a treatment for the disease.
|
|
|
|
InteRNA Technologies and Cenix BioScience Ink Research Agreement for miRNA Drug Discovery
18 November 2008
The research agreement comprises functional screens in human cell lines using InteRNA’s proprietary library of miRNAs.
|
|
|
|
Broad Institute of MIT and Harvard Expands its Fleet of SOLiD™ Systems from Applied Biosystems
18 November 2008
The Institute acquires five additional systems to expand studies of cancer and other complex human diseases.
|
|
|
|
Lorus Completes IND-Enabling Toxicology Studies for Lead Small Molecule Anticancer Drug LOR-253
12 November 2008
The drug LOR-253 shows induction of KLF4, a tumor suppressor factor that is reduced in a variety of important cancers.
|
|
|
|
HHS Secretary Leavitt Receives Personalized Medicine Coalition Award for Leadership
12 November 2008
The annual PMC award recognizes the contributions of Secretary Leavitt in advancing the frontier of personalized medicine.
|
|
|
|
Celldex Announces Licensing Agreement for Cancer Antibody Program
12 November 2008
Celldex enters an exclusive patent and know-how license agreement with the University of Southampton, UK, to develop human antibodies towards CD27.
|
|
|
|
UC Davis Researchers Discover Achilles' Heel in Pancreatic Cancer
12 November 2008
Researchers discovered a metabolic deficiency in pancreatic cancer cells that can be used to slow the progress of the deadliest of all cancers.
|
|
|
|
WuXi PharmaTech Signs new Collaboration Agreement with Pfizer
11 November 2008
WuXi in partnership with Pfizer will establish ADME assays to provide in vitro screening services on compounds WuXi synthesizes for Pfizer.
|
|
|
|
Stanford Study Recruits Twins for Pharmacogenetic Study of Opiates
11 November 2008
Investigators are recruiting twins for a study to determine whether addiction potential variations are due primarily to environmental factors or inherited traits.
|
|
|
|
QIAGEN Introduces CE-marked Molecular Assay for the Cancer Biomarker K-ras
11 November 2008
Pyrosequencing-based molecular test can detect and profile genetic mutations to predict responses to EGFR inhibitor therapies in colorectal cancer patients.
|
|
|
|
Geron Scientists and Collaborators Demonstrate TAT2 Enhances Antiviral Function of Immune Cells From HIV+ Donors
10 November 2008
Geron Corporation announced the publication of preclinical data on TAT2, a small molecule telomerase activator.
|
|
|
|
Nanogen Partners with Menarini to Capture European Molecular Diagnostic Market
10 November 2008
Both parties collaborate to commercialize CE marked IVD infectious disease kits based on Nanogen’s proprietary MGB technology.
|
|
|
|
InNexus Announces new EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces $1.25 Million Private Placement
10 November 2008
Company targets another large product and continues expansion of antibody therapeutics pipeline.
|
|
|
|
BTG Licenses Novel Anticancer Compound to Onyx Pharmaceuticals
10 November 2008
BTG to receive $13m upfront plus potential milestones of up to $307m and sales royalties on the development and commercialization of its BGC 945.
|
|
|
|
Regulus Therapeutics and Collaborators Discover Role of microRNA in Tumor Angiogenesis
07 November 2008
New findings highlight role of miR-296 in regulating pathways of angiogenesis and demonstrate potential new applications of microRNA therapeutics in cancer.
|
|
|
|
Protein 'Tubules' Free Avian Flu Virus from Immune Recognition
07 November 2008
Two domains or portions of the protein NS1 combine to form tiny tubules where double-stranded RNA is hidden from the immune system, researchers say.
|
|
|
|
Applied Biosystems and Asuragen Collaborate with the Critical Path Institute to Improve Drug Toxicity Screening
07 November 2008
TaqMan® gene expression arrays chosen as platform of choice to improve pre-clinical safety research.
|
|
|
|
Celera and Abbott Enter Collaboration to Identify Pharmacogenomic Markers
06 November 2008
Celera has entered into a research collaboration with Abbott to identify genetic markers for one of Abbott’s investigational compounds.
|
|
|
|
Moores UCSD Cancer Center Studying Novel Leukemia Vaccine for High-Risk Patients
05 November 2008
Researchers are conducting clinical trials of a novel therapy aimed at revving up the immune system to combat a particularly difficult-to-treat form of leukemia.
|
|
|
|
AltheaDx to Offer the DxS K-RAS Test for Clinical Studies
05 November 2008
DxS K-RAS test will assist US oncologists in studying patient response to cancer therapies in clinical trials.
|
|
|
|
Therapure Biopharma Announces Collaboration with BioVectra
05 November 2008
Both Companies have agreed to partner in the development of a PEGylated biologic drug target used for cancer treatments.
|
|
|
|
Alnylam and Collaborators Publish Research on a new Class of Chemically Modified RNAi Therapeutics
04 November 2008
New findings published in nature medicine describe “3p-siRNAs,” RNAi therapeutics that both silence specific genes and enhance desired immunostimulatory effects.
|
|
|
|
Neovacs Begins a Phase I/II Clinical Trial for the Treatment of Crohn’s Disease
04 November 2008
Neovacs commences the study at three study centres in South Africa with the candidate TNFa-kinoid.
|
|
|
|
Canopus BioPharma Announces Positive Results in Human Study of Peptide Cancer Vaccine
04 November 2008
Study analyzed at Southern Research Institute shows human antibodies generated by Canopus’s peptides have anti-cancer properties.
|
|
|
|
CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
04 November 2008
The new agreement extends the Multikine collaboration to also cover South Korea, the Philippines, Australia and New Zealand.
|
|
|
|
AltheaDx to Offer the DxS K-RAS Test for Clinical Studies
04 November 2008
DxS K-RAS test will assist US oncologists in studying patient response to cancer therapies in clinical trials.
|
|
|
|
Expression Analysis Adopts Cure Kids Cancer Coalition
03 November 2008
Fund-raising will begin at Upcoming American Society of Human Genetics Meeting.
|
|
|
|
High Throughput Imaging Speeds Analysis of Hormone Receptors
03 November 2008
A new high throughput microscopy technique enabled researchers at Baylor College of Medicine to analyze thousands of individual cells expressing androgen receptor.
|
|
|
|
Roche Diagnostics Licenses Rights to Use SYBR Green in Real Time PCR to Exiqon
03 November 2008
SYBR Green can provide the simplest and most economical format for detecting and quantitating PCR products in Real-Time PCR reactions.
|
|
|
|
Provectus Pharmaceuticals Adds Fifth Center to Phase 2 Clinical Trial of PV-10
03 November 2008
The Phase 2 clinical trial of the Company's lead oncology agent PV-10 at a fifth major center is now covering the northeastern United States.
|
|
|
|
Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository
31 October 2008
The Company receives approval from the South Africa Medicines Control Council to begin conducting Phase 1A trials on for ORMD 0802.
|
|
|
|
Researchers Identify Mechanism and Possible Drug Treatment for Growth of Nerve Tumors in Neurofibromatosis
31 October 2008
Researchers studying neurofibromatosis type 1 have found that the tumors are triggered by crosstalk between cells in the nerves and cells in the blood.
|
|
|
|
Cancer Requires Support from Immune System to Develop, UT Southwestern Researchers Report
31 October 2008
Tumors that grow around nerves in a rare genetic disease need cooperation from cells from the immune system in order to grow, reports a team of scientists.
|
|
|
|
Cancer Requires Support From Immune System to Develop, UT Southwestern Researchers Report
30 October 2008
Tumors that grow around nerves in a rare genetic disease need cooperation from cells from the immune system in order to grow, reports a team of scientists, including researchers from UT Southwestern Medical Center.
|
|
|
|
Exonhit Announces New Scientific Publications on the Use of SpliceArray™
30 October 2008
Company has announced the publication of five new key scientific articles based on the use of its owned designed microarrays.
|
|
|
|
ZyGEM and Advalytix Partner to Produce Innovative DNA Extraction Products
30 October 2008
New Collaboration brings ZyGEM’s temperature-controlled DNA extraction technology to Advalytix customers as private-label kits.
|
|
|
|
Vermillion Renews Strategic Alliance Agreement with Quest Diagnostics
30 October 2008
The extension will enable the companies to continue work on the development and commercialization of two tests, OVA1™ and VASCLIR™.
|
|
|
|
AstraZeneca and M. D. Anderson Renew Cancer Research Collaboration
30 October 2008
Both parties have renewed their collaboration to integrate pre-clinical and clinical research with a view to speeding up access to new medicines for cancer patients.
|
|
|
|
Sequenom Announces Exclusive Licensing Agreement with Xenomics for Noninvasive Prenatal Diagnostics Using Transrenal DNA
30 October 2008
Sequenom, Inc. announced that it has licensed from Xenomics, Inc. exclusive rights to patents (U.S. Patents 6,251,638 and RE 39,920, European Patent EP 0920539) for prenatal research and diagnostic products developed using fetal nucleic acids found in maternal urine.
|
|
|
|
Sequenom Announces Launch of RNA-Based Noninvasive Aneuploidy (RNA) Study
28 October 2008
Independent Study Will Document Performance of SEQureDx T21 Technology for Down Syndrome in 10,000 Pregnant Women
|
|
|
|
Geron Scientists and Collaborators Demonstrate Activity of Pancreatic Islet-like Cells Derived from Human Embryonic Stem Cells in Diabetes
28 October 2008
Survival of Diabetic Mice Improved After Transplantation of hESC-derived ILCs.
|
|
|
|
State Of The World's Health, WHO Releases The Global Burden Of Disease Study
28 October 2008
The World Health Organization (WHO) published a new assessment of the Global Burden of Disease, a study that provides a comprehensive picture of the global and regional state of health.
|
|
|
|
The Medicines Act Hits 40
24 October 2008
The 25th October 2008 will mark the 40th birthday of the Medicines Act.
For the past 40 years, the Act has served as the corner-stone of domestic medicines regulation, safe guarding public health.
|
|
|